Toxicity Study of the Pharmacological Pair of Encapsulated Citrobacter freundii C115H Methionine γ-Lyase/Methiin

S. V. Revtovich,V. V. Kulikova,V. S. Koval,A. D. Lyfenko,V. A. Kazakov,A. S. Chernov,G. B. Telegin,A. S. Zemskaya,N. V. Anufrieva,E. A. Morozova,P. N. Solyev
DOI: https://doi.org/10.1134/s0026893324700560
2024-12-19
Molecular Biology
Abstract:Acute and subchronic toxicity of the pharmacological pair based on encapsulated Citrobacter freundii C115H methionine γ-lyase enzyme/prodrug (methiin) was studied in female ICR mice. The drug showed a weak/moderate dose-dependent hepatotoxic effect. Most of the changes in liver morphology identified were insignificant or mild deviations from the norm. Long-term use of a single therapeutic dose per mouse of 1.5 U C. freundii C115H methionine γ-lyase @ (PEG−P(Asp) 70 /PLL 70 )-PIC-some/2 mg methiin led to a slight decrease in the weight of animals without obvious signs of intoxication. A quarter of the animals in this group had no deviations from the norm in liver morphology. No nephrotoxic effect was found in any study group.
biochemistry & molecular biology
What problem does this paper attempt to address?